Increased complements and high‑sensitivity C‑reactive protein predict heart failure in acute myocardial infarction

Liu,Danni; Qi,Xin; Li,Qi; Jia,Wenjun; Wei,Liping; Huang,Anan; Liu,Keqiang; Li,Zongjin

doi:10.3892/br.2016.793

Increased complements and high‑sensitivity C‑reactive protein predict heart failure in acute myocardial infarction

Authors:
- Danni Liu
- Xin Qi
- Qi Li
- Wenjun Jia
- Liping Wei
- Anan Huang
- Keqiang Liu
- Zongjin Li
View Affiliations

Affiliations: Department of Pathophysiology, School of Medicine, Nankai University, Tianjin 300071, P.R. China, Department of Cardiology, Tianjin Union Medical Center, Tianjin 300121, P.R. China
Published online on: October 27, 2016 https://doi.org/10.3892/br.2016.793
Pages: 761-765

Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )

Metrics: Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )

Cited By (CrossRef): 0 citations Loading Articles...

Abstract

The aim of the present study was to investigate whether the serum levels of complements and high‑sensitivity C‑reactive protein (hs‑CRP) in patients with acute myocardial infarction (AMI) are associated with the severity of myocardial injury. Consecutive patients (n=110) with AMI and 33 healthy individuals, who served as control subjects, were enrolled from May 2013 to February 2015. These patients were divided into two groups, those with ST segment elevation MI (STEMI) and those with non‑ST segment elevation MI (NSTEMI). The patients with STEMI exhibited progression to diastolic dysfunction and heart failure. Furthermore, the results revealed that the level of serum complement and hs‑CRP in patients with AMI increased rapidly when compared with the subjects from the control group, particularly in the STEMI patients, at different time-points. A statistically significant elevation of the complement and hs‑CRP levels was observed at day 3 after AMI in the STEMI group. The activation of complement and hs‑CRP following AMI may serve as a specific marker to successfully predict left ventricular dysfunction. Thus, biomarker‑based approaches may be adopted to identify the severity of AMI with distinct pathophysiologic responses in order to rationally implement clinical therapeutic strategies.

View Figures

View References

1	Du W, Tao H, Zhao S, He ZX and Li Z: Translational applications of molecular imaging in cardiovascular disease and stem cell therapy. Biochimie. 116:43–51. 2015. View Article : Google Scholar : PubMed/NCBI
2	Liu Y, Ye X, Mao L, Cheng Z, Yao X, Jia X, Mao D, Ou L, Li Z, Che Y, et al: Transplantation of parthenogenetic embryonic stem cells ameliorates cardiac dysfunction and remodelling after myocardial infarction. Cardiovasc Res. 97:208–218. 2013. View Article : Google Scholar : PubMed/NCBI
3	Frangogiannis NG: The inflammatory response in myocardial injury, repair, and remodelling. Nat Rev Cardiol. 11:255–265. 2014. View Article : Google Scholar : PubMed/NCBI
4	Liu N, Qi X, Han Z, Liang L, Kong D, Han Z, Zhao S, He ZX and Li Z: Bone marrow is a reservoir for cardiac resident stem cells. Sci Rep. 6:287392016. View Article : Google Scholar : PubMed/NCBI
5	Cai M, Shen R, Song L, Lu M, Wang J, Zhao S, Tang Y, Meng X, Li Z and He ZX: Bone marrow mesenchymal stem Cells (BM-MSCs) improve heart function in swine myocardial infarction model through paracrine effects. Sci Rep. 6:282502016. View Article : Google Scholar : PubMed/NCBI
6	Li Z, Lee A, Huang M, Chun H, Chung J, Chu P, Hoyt G, Yang P, Rosenberg J, Robbins RC, et al: Imaging survival and function of transplanted cardiac resident stem cells. J Am Coll Cardiol. 53:1229–1240. 2009. View Article : Google Scholar : PubMed/NCBI
7	Janssen BJ, Huizinga EG, Raaijmakers HC, Roos A, Daha MR, Nilsson-Ekdahl K, Nilsson B and Gros P: Structures of complement component C3 provide insights into the function and evolution of immunity. Nature. 437:505–511. 2005. View Article : Google Scholar : PubMed/NCBI
8	Wysoczynski M, Solanki M, Borkowska S, van Hoose P, Brittian KR, Prabhu SD, Ratajczak MZ and Rokosh G: Complement component 3 is necessary to preserve myocardium and myocardial function in chronic myocardial infarction. Stem Cells. 32:2502–2515. 2014. View Article : Google Scholar : PubMed/NCBI
9	Zacho J, Tybjaerg-Hansen A, Jensen JS, Grande P, Sillesen H and Nordestgaard BG: Genetically elevated C-reactive protein and ischemic vascular disease. N Engl J Med. 359:1897–1908. 2008. View Article : Google Scholar : PubMed/NCBI
10	Melis JP, Strumane K, Ruuls SR, Beurskens FJ, Schuurman J and Parren PW: Complement in therapy and disease: Regulating the complement system with antibody-based therapeutics. Mol Immunol 67 (2 Pt A). 117–130. 2015. View Article : Google Scholar
11	Epelman S, Liu PP and Mann DL: Role of innate and adaptive immune mechanisms in cardiac injury and repair. Nat Rev Immunol. 15:117–129. 2015. View Article : Google Scholar : PubMed/NCBI
12	Thygesen K, Alpert JS, Jaffe AS, Simoons ML, Chaitman BR, White HD, Thygesen K, Alpert JS, White HD, Jaffe AS, et al: Joint ESC/ACCF/AHA/WHF Task Force for Universal Definition of Myocardial Infarction; Authors/Task Force Members Chairpersons; Biomarker Subcommittee; ECG Subcommittee; Imaging Subcommittee; Classification Subcommittee; Intervention Subcommittee; Trials & Registries Subcommittee; Trials & Registries Subcommittee; Trials & Registries Subcommittee; Trials & Registries Subcommittee; ESC Committee for Practice Guidelines (CPG); Document Reviewers: Third universal definition of myocardial infarction. J Am Coll Cardiol. 60:1581–1598. 2012. View Article : Google Scholar : PubMed/NCBI
13	White H, Thygesen K, Alpert JS and Jaffe A: Universal MI definition update for cardiovascular disease. Curr Cardiol Rep. 16:4922014. View Article : Google Scholar : PubMed/NCBI
14	Karahan Z, Uçaman B, Uluğ AV, Aydınalp Ö, Uğurlu M, Çevik K, Kaya İ and Öztürk Ö: Effect of hematologic parameters on microvascular reperfusion in patients with ST-segment elevation myocardial infarction treated with primary percutaneous coronary intervention. Angiology. 67:151–156. 2016. View Article : Google Scholar : PubMed/NCBI
15	Liu Z, Tang Q, Wen J, Tang Y, Huang D, Huang Y, Xie J, Luo Y, Liang M, Wu C, et al: Elevated serum complement factors 3 and 4 are strong inflammatory markers of the metabolic syndrome development: A longitudinal cohort study. Sci Rep. 6:187132016. View Article : Google Scholar : PubMed/NCBI
16	Zethelius B, Berglund L, Sundström J, Ingelsson E, Basu S, Larsson A, Venge P and Arnlöv J: Use of multiple biomarkers to improve the prediction of death from cardiovascular causes. N Engl J Med. 358:2107–2116. 2008. View Article : Google Scholar : PubMed/NCBI
17	Dai S, Yuan F, Mu J, Li C, Chen N, Guo S, Kingery J, Prabhu SD, Bolli R and Rokosh G: Chronic AMD3100 antagonism of SDF-1alpha-CXCR4 exacerbates cardiac dysfunction and remodeling after myocardial infarction. J Mol Cell Cardiol. 49:587–597. 2010. View Article : Google Scholar : PubMed/NCBI
18	Frangogiannis NG: The immune system and the remodeling infarcted heart: Cell biological insights and therapeutic opportunities. J Cardiovasc Pharmacol. 63:185–195. 2014. View Article : Google Scholar : PubMed/NCBI
19	Thorp EB: Mechanisms of failed apoptotic cell clearance by phagocyte subsets in cardiovascular disease. Apoptosis. 15:1124–1136. 2010. View Article : Google Scholar : PubMed/NCBI
20	Giasuddin AS, ElMahdawi JM and ElHassadi FM: Serum complement (C3, C4) levels in patients with acute myocardial infarction and angina pectoris. Bangladesh Med Res Counc Bull. 33:98–102. 2007. View Article : Google Scholar : PubMed/NCBI
21	Mellbin LG, Bjerre M, Thiel S and Hansen TK: Complement activation and prognosis in patients with type 2 diabetes and myocardial infarction: A report from the DIGAMI 2 trial. Diabetes Care. 35:911–917. 2012. View Article : Google Scholar : PubMed/NCBI
22	Ribeiro DR, Ramos AM, Vieira PL, Menti E, Bordin OL Jr, Souza PA, Quadros AS and Portal VL: High-sensitivity C-reactive protein as a predictor of cardiovascular events after ST-elevation myocardial infarction. Arq Bras Cardiol. 103:69–75. 2014.PubMed/NCBI
23	Timmers L, Pasterkamp G, de Hoog VC, Arslan F, Appelman Y and de Kleijn DP: The innate immune response in reperfused myocardium. Cardiovasc Res. 94:276–283. 2012. View Article : Google Scholar : PubMed/NCBI
24	Christenson E and Christenson RH: The role of cardiac biomarkers in the diagnosis and management of patients presenting with suspected acute coronary syndrome. Ann Lab Med. 33:309–318. 2013. View Article : Google Scholar : PubMed/NCBI
25	Wildgruber M, Swirski FK and Zernecke A: Molecular imaging of inflammation in atherosclerosis. Theranostics. 3:865–884. 2013. View Article : Google Scholar : PubMed/NCBI